Continuous positive airway pressure (CPAP) is the most widely used therapy for obstructive sleep apnoea (OSA). Despite its general efficacy, oxygen desaturation due to hypoventilation persists in some patients. The present study analysed the factors which are associated with this primary failure and, moreover, examined the effect of a bilevel positive airway pressure (BiPAP) trial.
Introduction
Nocturnal ventilation with nasal continuous positive airway pressure (CPAP) is generally accepted as the treatment of choice in obstructive sleep apnoea/hypopnoea syndrome (OSA) (1) . It abolishes rapidly obstructive apnoea and hypopnoea (2) by increasing the pressure in the pharyngeal airway, thus reversing the transmural pressure gradient across the pharyngeal airway (3) . It is based on the pathophysiology of the disease and therefore acts as a pneumatic splint. Besides these direct effects of CPAP on respiration, fragmentation of sleep is reduced, which results in an improvement in daytime sleepiness and cognitive performance (4) . It is therefore concluded that long-term compliance is, in part, the result of a careful initiation of this therapy and the subsequent reversal of sleep fragmentation (5) .
The level of pressure required to eliminate apnoea, hypopnoea and snoring must be individually determined in ranges from low to high. Even if silent flow limitation is eliminated, a subgroup of patients continue to have marked oxygen desaturation mainly due to hypoventilation and subsequently exhibit nocturnal CO, retention (6) . The therapeutic efficacy and the incidence of side-effects of CPAP therapy was investigated in a large series of 1140 patients with obstructive sleep apnoea representing all degrees of severity from obstructive snoring with arousals to the Pickwickian syndrome (7) . The apnoealhypopnoea index (AHI) could not be lowered under 10 in 5.5% of the whole group, partly because of central apnoea or hypoventilation (7) . Up to now, it was not clear why some patients exhibit hypoventilation despite CPAP and which factors are associated with the initial failure of CPAP. These patients were considered to have a reduced ventilatory drive and have daytime hypercapnia (8) . Consequently, nasal intermittent positive pressure ventilation (NIPPV) was performed as a short-term intervention, before switching back to CPAP therapy (8) .
The purpose of the present study was to analyse the factors which are associated with a primary failure in the intial CPAP therapy in order to identify these patients before starting CPAP therapy. Therefore, patients with OSA who resisted refractory to initial CPAP therapy were compared with an age-and AHI-matched control group of patients who responded to CPAP therapy. Furthermore, the former were tested with intermittent positive pressure ventilation by pressure preset ventilators in the controlled mode (bilevel), and this paper reports on the authors' experience with this mode of ventilation over a 3-month period.
Methods
Nasal CPAP therapy was initiated in 146 patients with OSA that was confirmed by polysomnography over a 15-month period. <Thirteen patients (Group A) failed to respond to CPAP, i.e. defined as a remaining AH1 of 25 or a mean oxygen saturation of ~90% due to hypoventilation. Anthropometric data, lung-function test, blood gases at rest and at exercise before starting ventilation therapy, and polysomnographic data were compared to an age-and AHI-matched control group successfully treated by CPAP (Group B). Age was the primary match criteria and AH1 the secondary one. Patients with central sleep apnoea or obstructive lung disease (FEV,/ VC ~60%) were excluded in both groups.
Standard polysomnography was performed in the sleep laboratory. Two leads of electroencephalogram (C,A,; C,A,), two leads of electro-oculogram, a submental electromyogram, an anterior tibia1 electromyogram and an electrocardiogram were continuously registered by surface electrodes. Respiration was also recorded continuously: oro-nasal airflow, abdominal and chest wall movements by inductive-plethysmography and transcutaneous oxygen saturation by finger oxymeter. Snoring sounds were recorded by larynx microphone. In addition, mask pressures were recorded in cases of nasal ventilation.
All variables were recorded by a computerized system (NewMedics, ohringen, Germany). Sleep was staged manually according to standard criteria of Rechtschaffen and Kales (9) . Apnoea was defined as a cessation of airflow for more than 10 s regardless of oxygen saturation, and it was classified as obstructive, central or mixed in the presence or absence of continued respiratory efforts. Hypopnoea was defined as a reduction in airflow of at least 50% followed either by an oxygen desaturation of at least 4 percentage points or an arousal. The total number of apnoea and hypopnoea divided by total sleep time make up the apnoea index (AI) and the hypopnoea index (HI). The sum of AI and HI then became the apnoealhypopnoea index (AHI), which established the diagnosis of obstructive sleep apnoea at 210.
Standard lung function tests and arterial blood gas tensions at rest were measured in the sitting position. Arterial blood gas tensions at exercise were also measured in the sitting position on a cycle ergometer with a work load of 50 W in a 6-min interval. Mouth occlusion pressure measurements were obtained as follows (10) : a magnetic valve in front of the pneumotachograph was completely occluded with the onset of inspiration and reopened automatically after 120 ms (PO.l). In the same way, PO.1 max was determined during maximal voluntary inspiratory effort. Since PO. 1 reflects actual inspiratory pressure generation and PO.1 max is representative of maximal inspiratory pressure generation, the PO. l/PO. 1 max ratio is an adequate index for assessing the relative force of the inspiratory muscles (10) . In order to assess a functional stenosis of the trachea, roentgenograms of the trachea were obtained during Valsalva and Mueller manoeuvre. Pulmonary artery pressure (Pap) measurements were performed noninvasively by Doppler echocardiography (pulmonary hypertension defined by systolic PAP 2 30 mmHg). Daytime sleepiness and dyspnoea were graded by visual analogue scales.
Patients were instructed to use the CPAP device (Weinmann, Hamburg, Germany) at a low pressure during the daytime to get acquainted with the system. Nasal CPAP therapy was started in the second sleep study night. The mask pressure was set at 5 cm H,O at the beginning and raised by 1 cm H,O increments until apnoeas, hypopnoeas and snoring were abolished. Hypoventilation was defined as 
Results

STUDY POPULATION
Failure in CPAP therapy occurred in 13 patients (8.9%) out of a total of 146 patients over a 15-month period. This failure was due to a remaining AH1 of 25 in all cases and due to a mean oxygen saturation of ~90% in seven cases (54%) despite CPAP with high pressure (2 12 cm H,O). These patients (Group A) were significantly (WO.001) more obese than the control group that had been successfully treated with CPAP (Group B). Anthropometric data of both groups are listed in Table 1 . Non-responders of CPAP complained significantly more about dyspnoea than responders, had significantly worse blood gas values at rest and exhibited respiratory type II failure during exercise (Table 2) . Moreover, PaCO, at rest changed for the worse during exercise, revealing a disorder in ventilation (Fig. l) , whereas it improved in the control group (Fig. 2) . Spirometric parameters were the same in both groups. Data of blood gas analysis and lung function are given in Table 2 . Mouth occlusion pressures were significantly different according to PO.1 (Group A: 0.31 kPa, Group B: 0.18 kPa; WO.001) and PO.UPO.1 max ratio (Group A: 22.5% Group B: 8.3%; P<O.OOl). The PO.1 max was not significantly different in either group (1.85 kPa vs 2.16 kPa). No functional stenosis was found in the roentgenograms'of the trachea.
POLYSOMNOGRAPHY
All patients had moderate or severe obstructive apnoeal hypopnoea syndrome with no significant differences in apnoea or hypopnoea index between the groups (Table 2) . . The amount of central apnoeas in both groups was less than 10% of total apnoeas (2 vs 6). Patients in Group A had significantly lower mean and minimal nocturnal oxygen saturation than patients in Group B, and spent significantly more time with an oxygen saturation lower than 90% (Table 2 ). Even when CPAP was administered, the mean and minimal noctural oxygen saturation was significantly different between the groups, although CPAP pressure was significantly higher in Group A patients ( Table 2 ). Most of the breathing disorders which occurred under CPAP were phases of hypoventilation without perceptible upper airway obstruction, and were classified as hypopnoea.
PREDICTIVE FACTORS FOR FAILURE OF CPAP THERAPY
The following factors were significantly associated with the primary failure of CPAP therapy in univariate analysis: BMI, mean PaO, at rest and at exercise, mean PaCO, at rest and at exercise, mean nocturnal SaO, and the percentage of time spent at ~90% of SaO,. In the multivariate analysis, the only factor which was independently associated with the initial failure of CPAP therapy was the with BiPAP (Fig. 3) . , apnoea/hypopnoea. These patients were significantly more obese and had worse awake blood gas values at rest and at exercise than patients treated successfully with CPAP. The percentage of time spent at <90% of nocturnal SaO, was the only factor which was independently associated with the initial failure of CPAP. BiPAP ventilation in the controlled mode led to a sufficient treatment of apnoea, hypopnoea and hypoventilation. Moreover, awake blood gas values improved significantly after a 3-month treatment period.
Several therapeutic approaches for the management of OSA are available. CPAP is generally accepted as the treatment of choice and the most widely used therapy. Data based on randomized studies about its efficacy in comparison to other treatment modalities such as conservative management, surgery or oral appliances demonstrated that CPAP is an effective treatment (11, 12) , but compliance is a main concern of long-term management (5, 13) . However, in a small group of patients treated with CPAP, prolonged hypoventilation persisted despite CPAP, resulting in an inadequately high AH1 or a still reduced mean nocturnal oxygen saturation (6, 7) . Only limited data on the primary failure of CPAP are available. Becker et al. (7) reported their experience with CPAP therapy in a large series of patients. They found a primary failure of CPAP defined as a persistent AHI of 2 10 in 5.5% of the whole group of 1140 patients, partly because of central apnoea or hypoventilation. The present authors defined a primary failure of CPAP as a pesisting AHI 25, bearing in mind that even a lower AH1 may be associated with persistent symptoms of daytime hypersomnolence. In addition, if mean oxygen saturation was <90%, this was defined as failure as well, since ventilation therapy should ensure an appropriate nocturnal oxygenation.
The aim of this study was to analyse the factors that are associated with the initial failure of CPAP, since hypoxaemia in the course of hypoventilation may have adverse effects in patients at risk (6) . To the authors' FAILURE OF CPAP IN OSA 213 knowledge, this is the first study in which these factors have been analysed systematically and which includes a control group of successfully treated patients for comparison.
Patients of the control group were obese with a median BMI of 31 kg m -2 but patients of the CPAP-failure group were morbidly obese with a median BMI of 44 kg m ~ '. The impared awake blood gas values with hypercapnia in almost half of this group (six of 13 patients) suggests that these patients exhibited obesity hypoventilation syndrome (OHS), which is characterised by extreme obesity, hypercapnic respiratory failure (14, 15) and additionally by OSA in most cases (16, 17) . Factors considered to be critical determinants for the development of obesity hypoventilation are mechanical loading, abnormal chest wall mechanics, impaired neuromuscular coupling (l&18), and impaired ventilatory control (19) whereas abnormalities in respiratory control may be more a consequence than a cause of OHS. Pharyngeal obstruction is abolished by CPAP, but hypoventilation due to blunted ventilatory control persists in these patients. Patients without hypercapnic failure may compensate for the effects of obesity on elastic load and respiratory resistance when awake (20) , but when asleep and in the supine position with additional mass loading and reduced functional residual capacity (FRC) (21) , the balance between ventilatory control and mechanical load is impaired and hypoventilation results despite CPAP. In addition, ventilatory muscle fatigue due to an obesity-related alteration in thoracic mechanics may promote hypoventilation despite CPAP. The PO.UPO.1 max ratio as an adequate index for assessing the relative force of the inspiratory muscles (10) was impaired in the CPAPfailure group, indicating an impaired respiratory muscle strength awake. The percentage of time spent at ~90% of oxygen saturation as the only factor which was independently associated with CPAP failure may represent the severity of impaired nocturnal ventilation, since all patients were matched for AHI. This is in accordance with findings of greater oxygen desaturations during sleep in patients with OHS than in patients with eucapnic OSA (22) . A limitation of the present study may be the absence of nocturnal capnography and pneumotachography in order to quantify exactly the amount of hypoventilation leading to nocturnal hypoxemia and hypercapnia. Another limitation of the present study may be that ventilatory response measurements were not performed when patients were awake. Nevertheless, PaCO, at exercise changed for the worse in the CPAP-failure group, indicating a latent ventilatory failure awake, whereas in the control group, it improved during exercise. This study excluded patients with flow limitation that revealed chronic obstructive pulmonary disease as a possible cause of impaired blood gas values. Moreover, no statistical association was found between FEV, or FEV,/VC ratio and CPAP failure.
BiPAP in the spontaneous mode had first been applied to prevent both complete upper airway obstruction and the oxyhaemoglobin desaturations events associated with persistent partial obstructions at a mean pressure lower than conventional CPAP (23) . However, all the patients in this study (23) superior to CPAP with regard to response. One of the present study patients was treated with such a device, because he did not tolerate the control mode. AH1 still remained at 6.3 and PaCO, was slightly elevated after a 3-month treatment period in this patient. Nevertheless, it is not clear if BiPAP in the controlled mode is superior to the spontaneous mode in these patients. Both devices do prevent upper airway obstruction sufficiently, but the controlled mode may adequately prevent hypoventilation and therefore normalize chronically blunted central ventilatory drive (24) . In addition, this mode may improve ventilatory muscle strength or endurance (24) . Piper and Sullivan performed nasal positive pressure ventilation (NIPPV) in the controlled mode using a volume-cycled ventilator in 13 patients with OSA who failed to respond to initial CPAP therapy (8) . All of these patients were grossly obese and hypercapnic. After 7-18 days of NIPPV, nine of the 13 patients switched back to a regimen of nocturnal CPAP, while three patients required a longer period of up to 3 months before adequate nocturnal ventilation could be maintained. One patient required long-term NIPPV. The type of ventilator chosen may be potentially more comfortable and may compensate for mild-to-moderate mouth leaks, but the issue of CO, rebreathing is not clear (25) . Further studies are needed to clarify if one device is superior to another in this specific group of patients, and which patients should or could switch back to a CPAP device.
In conclusion, patients with OSA who resist initial CPAP are morbidly obese with impaired awake blood gas values. The percentage of time spent at ~90% of SaO, is independently associated, and therefore a predictive factor of failure of initial CPAP. BiPAP in the control mode is adequate for nocturnal ventilation in these patients and improves awake blood gas values after 3 months of treatment.
